Gene-Disorder Association · Article
Gene
HNF4A Hepatocyte Nuclear Factor 4 Alpha
×
First reported
1997
Supporting publications
90
Manually curated Approved treatment annotated
Association Review
In brief The association between HNF4A (Hepatocyte Nuclear Factor 4 Alpha) and Type 2 Diabetes Mellitus is well established and manually curated, with its 5 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic variants, causative variation, and a susceptibility locus.
Sources
5
Clinical variants
96
Symptoms
9
Compounds
1
Trials
84 of 183 via HNF4A compounds
Publications
90
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 5 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Type 2 Diabetes Mellitus
The disorder 12 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features 3 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis 96 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Population genetics
GWAS signals 2 GWAS phenotypes
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
08
Genomic context
Regulatory context 1 regulatory element
GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.
Request access
09
Mechanism overlap
Shared mechanisms Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
10
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
11
Human studies
Clinical trials 183 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
90 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
13
Provenance
References & sources 20 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access